Suchergebnisse - "Buti, Maria"

PubPharm (489)

21

Emergency department contribution to HCV elimination in the Iberian Peninsula

enthalten in: International journal of emergency medicine | 2024

von Buti, M. | Vaz-Pinto, I. | Magno Pereira, V. | +18

22

The elimination of hepatitis D as a public health problem : Needs and challenges

enthalten in: Journal of viral hepatitis | 2024

von Vanwolleghem, T. | Armstrong, P. | Buti, M. | +4

23

Integrating viral hepatitis management into the emergency department : A further step towards viral hepatitis elimination

enthalten in: JHEP reports : innovation in hepatology | 2024

von Llaneras, J. | Ruiz-Cobo, J. | Rando-Segura, A. | +16

24

HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy

enthalten in: Gastroenterology | 2024

von Sonneveld, M. | Chiu, S. | Park, J. | +26

25

Impact of hepatitis D reflex testing on the future disease burden : A modelling analysis

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2023

von Buti, M. | Domínguez-Hernández, R. | Palom, A. | +2

26

Community-based screening enhances hepatitis B virus linkage to care among West African migrants in Spain

enthalten in: Communications medicine | 2023

von Picchio, C. | Nomah, D. | Rando-Segura, A. | +13

27

The significant IgG4 infiltrate in autoimmune hepatitis is associated with a greater ductular reaction and more advanced liver disease

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2023

von Barreira-Díaz, A. | Salcedo-Allende, M. | Martínez-Valle, F. | +3

28

In-Host HEV Quasispecies Evolution Shows the Limits of Mutagenic Antiviral Treatments

enthalten in: International journal of molecular sciences | 2023

von Colomer-Castell, S. | Gregori, J. | Garcia-Cehic, D. | +12

29

Hepatocellular carcinoma surveillance - utilization, barriers and the impact of changing aetiology

enthalten in: Nature reviews. Gastroenterology & hepatology | 2023

von Huang, D. | Singal, A. | Kanwal, F. | +5

30

mTOR inhibitors a potential predisposing factor for chronic hepatitis E : Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels)

enthalten in: Gastroenterologia y hepatologia | 2023

von Riveiro-Barciela, M. | Roade, L. | Martínez-Camprecios, J. | +21